David Bol
11Patents
5h-index
27Co-inventors
58Inventor score
Filing activity: Apr 26, 2001 → Aug 9, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7223557B2 | Polynucleotide encoding a TRP channel family member, TRP-PLIK2 | Chemistry; Metallurgy | 14 | Expired |
| US7049096B2 | Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1 | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7345148B2 | Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8124729B2 | Splice variants of human G-protein coupled receptor HGPRBMY29 (HGPRMBY29SV2) | Emerging Cross-Sectional Technologies | 9 | Active |
| US7276354B2 | Polynucleotides encoding a novel human G-protein coupled receptor splice variant, HGPRBMY29SV2 | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6534531B2 | Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy | Chemistry; Metallurgy | 2 | Expired |
| US7427473B2 | Chemo-centric selection of disease-related genetic profiles | Chemistry; Metallurgy | 2 | Expired |
| US7265260B2 | Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors | Chemistry; Metallurgy | 1 | Expired |
| US7635758B2 | Antibodies directed to G-protein coupled receptor HGPRBMY29sv1 | Emerging Cross-Sectional Technologies | 0 | Active |
| US7049088B2 | PRMTs as modifiers of the p53 pathway and methods of use | Physics | 0 | Expired |
| US7304141B2 | Human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1 | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.